MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2017 International Congress

    Self-awareness of cognitive functions in Parkinson’s disease patients with and without mild cognitive impairment.

    M. Hoock, F. Maier, R. Kaur, C. Eggers, L. Timmermann (Cologne, Germany)

    Objective: To examine whether Parkinson’s disease (PD) patients with or without mild cognitive impairment (MCI) show impaired self-awareness (ISA) of their cognitive abilities. Background: PD…
  • 2017 International Congress

    Subjective cognitive decline reflects recent cognitive change in non-demented patients with Parkinson’s disease

    J.Y. Hong, Y. Lee, M. Sunwoo, Y. Sohn, P.H. Lee (Wonju, Republic of Korea)

    Objective: We investigated whether subjective cognitive decline (SCD) can reflect recent cognitive change in patients with Parkinson’s disease (PD) who had shown non-demented cognitive performance…
  • 2017 International Congress

    The Effect of Anxiety on Cognition in Parkinson’s Disease

    S. Anderson, G. Stebbins, B. Bernard, A. Negron, J. Goldman (Chicago, IL, USA)

    Objective: Our study examined the effect of anxiety on cognition in Parkinson’s disease (PD) patients without cognitive impairment, mild cognitive impairment and dementia. Background: Anxiety…
  • 2017 International Congress

    Interactions between amyloid-β and microglial activation in Parkinson’s disease

    C. Ghadery, Y. Koshimori, J. Kim, S. Coakeley, M. Harris, L. Christopher, P. Rusjan, A. Lang, S. Houle, A. Strafella (Toronto, ON, Canada)

    Objective: To evaluate the relationship between microglial activation and amyloid-β deposition in the brain using positron emission tomography (PET) in Parkinson’s disease (PD) with normal…
  • 2017 International Congress

    U-shaped dopamine resting state connectivity response function related to working memory performance in adults with early-stage Parkinson’s disease

    A. Metcalfe, S. Udow, H. Sharmarke, Z. Shirzadi, D. Long, S. Duff-Canning, C. Marras, A. Lang, B. MacIntosh, M. Masellis (Toronto, ON, Canada)

    Objective: Appraise how cognitive performance and neural response is affected by nigrostriatal denervation in early-stage Parkinson’s disease (PD). Background: Cognitive dysfunction in PD is heterogeneous…
  • 2017 International Congress

    General Anesthesia and Parkinson’s Disease

    C.-W. CHEN, K.-B. CHEN, Y.-C. KUO (TAICHUNG, Taiwan)

    Objective: Postoperative cognitive dysfunction is common among the elderly. These changes may even be so severe that some elderly people actually become demented after undergoing…
  • 2017 International Congress

    A PSP-like phenotype accompanies rapidly progressive dementia

    M. Dale, D. Erten-Lyons, F. Bittner, H.-Y. Jong, D. Bourdette, R. Woltjer (Charleston, SC, USA)

    Objective: We describe a patient with a progressive supranuclear palsy (PSP)-like phenotype and a rapidly progressive dementia, who was found to have an unknown CSF…
  • 2017 International Congress

    Non-motor symptoms in ACDY5-associated disease

    C. Amlang, M. Vidailhet, M. Amlang (Bronx, NY, USA)

    Objective: To describe non-motor symptoms in a case of ACDY5-associated disease. Background: The hereditary dyskinesia syndrome caused by an ACDY5 mutation was first described in…
  • 2017 International Congress

    RBD predicts the cognitive impairment in Parkinson’s disease

    E. Stefanova, T. Stojkovic, I. Stankovic, V. Kostic (Belgrade, Serbia)

    Objective: To assess the relationship between the presence of Rapid eye movement  sleep and behavior disorders RBD and the cognitive decline of non-demented patients with PD in…
  • 2017 International Congress

    Cognitive strategy use during daily activities in people with Parkinson’s Disease

    I. Sturkenboom, E. Steultjens, M. Nott, C. Chapparo (Nijmegen, Netherlands)

    Objective: To identify difficulties in cognitive strategy use observed in people with Parkinsons’s disease (PD) during performance of everyday activities. Background: People use cognitive strategies…
  • « Previous Page
  • 1
  • …
  • 98
  • 99
  • 100
  • 101
  • 102
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley